High-fidelity tumouroids: accelerating next-generation personalised medicine

Project Member(s): Gallego Ortega, D.

Funding or Partner Organisation: National Health & Medical Research Council (NHMRC - Ideas Grants)
National Health & Medical Research Council (NHMRC - Ideas Grants)

Start year: 2022

Summary: Anti-cancer drug testing using in vitro models are unable to recapitulate the complexity of human tumours, hindering the application of more effective therapeutic strategies. We have created ALTEN, a tissue-engineering system capable of preserving tumour biopsies maintaining their original environment. ALTEN allows parallel testing of different therapies on each patient’s biopsy, accurately identifying the most effective treatment for each patient, facilitating a personalised medicine approach.

FOR Codes: Cancer and Related Disorders, Biomedical engineering, Solid tumours, Cancer cell biology, Efficacy of medications

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.